Mental Health Disorders Now No. 1 Cause of Disability Worldwide
Medically reviewed by Drugs.com
via HealthDayFRIDAY, May 29, 2026 — Mental health disorders are now the leading cause of disability worldwide, according to a major new study.
Researchers found nearly 1.2 billion people were living with a mental health disorder in 2023 — almost twice as many as in 1990.
"These rising trends may reflect both the lingering effects of pandemic-related stress and longer-term structural drivers such as poverty, insecurity, abuse, violence and declining social connectedness," said first author Damian Santomauro, an associate professor at the Queensland Center for Mental Health Research in Australia.
The global analysis looked at data from 204 countries and found anxiety and depression have surged since the COVID-19 pandemic.
Rates of major depressive disorder have risen about 24% since 2019, while anxiety disorders skyrocketed more than 47%.
"Our findings show that mental disorder burden peaks among 15-to-19-year-olds, which is a critical developmental period that can shape trajectories for education, employment and relationships," said coauthor Alize Ferrari, who is also from the Queensland Center for Mental Health Research.
The study also found that women are disproportionately affected, possibly due to caregiving pressures, gender inequality and higher rates of abuse.
Addressing the growing crisis will require more investment in mental health care, expanded access to treatment and better support for at-risk populations, the authors said.
The findings were recently published in The Lancet.
Sources
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2026-05-29 21:56
Read more
- Acting NIAID Chief Steps Down Amid Ebola, Hantavirus Concerns
- HRS: Atrial Arrhythmia Recurrence Lower in Persistent A-Fib With Pulsed Field Ablation Versus Antiarrhythmics
- Common Food Preservatives Linked to Major Heart Problems
- Quitting Smoking Might Lower Your Dementia Risk
- Coya Therapeutics Has Been Granted U.S. FDA Fast Track Designation for COYA 302 for the Treatment of Amyotrophic Lateral Sclerosis (ALS)
- Atropine Shows Effect on Superficial Retinal Perfusion
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions